)
Phillip J. Minnick, Ph.D.
Phillip (P.J.) Minnick is an associate in Knobbe’s San Diego office focused on client counseling, opinion and due diligence work, and patent preparation and prosecution in the biotechnology, agrotechnology, and medical device and therapeutics arts.
P.J. currently represents clients in diagnostics, stem cell technologies, medical devices, next generation sequencing, amplification technologies, and the large molecule space (including antibodies and protein engineering).
P.J. obtained his Ph.D in Biochemistry and Molecular Biology from Baylor College of Medicine, with an emphasis on genetics. His research focused on elucidating the molecular mechanisms responsible for the evolution of drug resistance, including antibiotics and chemotherapies.
Prior to joining Knobbe, P.J. served in the United States Navy as a submarine nuclear propulsion plant operator on board the USS Springfield.
Zhai Y, Pribis JP, Dooling SW, Garcia-Villada L, Minnick PJ, Xia J, Liu J, Mei Q, Fitzgerald DM, Herman C, Hastings PJ, Costa-Mattioli M, Rosenberg SM. Drugging evolution of antibiotic resistance at a regulatory network hub. Sci Adv. 2023 Jun 23;9(25):eadg0188. doi: 10.1126/sciadv.adg0188. Epub 2023 Jun 23. PMID: 37352342; PMCID: PMC10289659.
Zhai Y, Minnick PJ, Pribis JP, Garcia-Villada L, Hastings PJ, Herman C, Rosenberg SM. ppGpp and RNA-polymerase backtracking guide antibiotic-induced mutable gambler cells. Mol Cell. 2023 Apr 20;83(8):1298-1310.e4. doi: 10.1016/j.molcel.2023.03.003. Epub 2023 Mar 24. PMID: 36965481; PMCID: PMC10317147.
Medical Device Blog